Amended Statement of Beneficial Ownership (sc 13d/a)
December 11 2020 - 5:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D/A
Under the Securities Exchange Act of
1934
(Amendment No. 1)
Acadia
Healthcare Company, Inc.
(Name of Issuer)
Common
Stock, $.01 par value
(Title of Class of Securities)
00404A109
(CUSIP Number)
Jason Carri
P2 Capital Partners, LLC
590 Madison Avenue
25th Floor
New York, NY 10022
(212)
508-5500
(Name, Address and
Telephone Number of Person Authorized to Receive Notices and Communications
December 10,
2020
(Date of Event which Requires Filing of
this Statement)
If the filing person has previously filed a statement on Schedule
13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e),
240.13d-1(f) or 240.13d-1(g), check the following box ¨
Note:
Schedules filed in paper format shall include a signed original and five copies of the schedule including all exhibits.
See Rule 13d-7(b) for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out
for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent
amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall
not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
CUSIP No. 00404A109 13D
1
|
NAME OF REPORTING PERSON
P2 Capital Partners, LLC
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY).
20-2436330
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) x
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
|
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR (2e)
o
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
4,313,620
|
9
|
SOLE DISPOSITIVE POWER
0
|
10
|
SHARED DISPOSITIVE POWER
4,313,620
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,313,620
|
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
o
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.8%
|
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
CO
|
CUSIP No. 00404A109 13D
1
|
NAME OF REPORTING PERSON.
P2 Capital Master Fund I, L.P.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY).
98-0515452
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP (SEE INSTRUCTIONS)
(a) ¨
(b) x
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
|
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Cayman Islands, British West Indies
|
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
2,217,866
|
9
|
SOLE DISPOSITIVE POWER
0
|
10
|
SHARED DISPOSITIVE POWER
2,217,866
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,217,866
|
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (11)
2.5%
|
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
CUSIP No. 00404A109 13D
1
|
NAME OF REPORTING PERSON.
P2 Capital Master Fund VI, L.P.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY).
27-2915390
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP (SEE INSTRUCTIONS)
(a) ¨
(b) x
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
|
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
2,095,754
|
9
|
SOLE DISPOSITIVE POWER
0
|
10
|
SHARED DISPOSITIVE POWER
2,095,754
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY
EACH REPORTING PERSON
2,095,754
|
1
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (11)
2.4%
|
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
CUSIP No. 00404A109 13D
1
|
NAME OF REPORTING PERSON.
P2 Capital Master Fund XII, L.P.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY).
81-3876089
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP (SEE INSTRUCTIONS)
(a) ¨
(b) x
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
|
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS
IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
0
|
9
|
SOLE DISPOSITIVE POWER
0
|
10
|
SHARED DISPOSITIVE POWER
0
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY
EACH REPORTING PERSON
0
|
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT
IN ROW (11)
0.0%
|
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
CUSIP No. 00404A109 13D
1
|
NAME OF REPORTING PERSON.
Claus Moller
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY).
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER
OF A GROUP (SEE INSTRUCTIONS)
(a) ¨
(b) x
|
3
|
SEC USE ONLY
|
4
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
|
5
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e)
¨
|
6
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Denmark
|
NUMBER OF
SHARES BENEFICIALLY OWNED BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE VOTING POWER
0
|
8
|
SHARED VOTING POWER
4,313,620
|
9
|
SOLE DISPOSITIVE POWER
0
|
10
|
SHARED DISPOSITIVE POWER
4,313,620
|
11
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,313,620
|
12
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
(SEE INSTRUCTIONS)
¨
|
13
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.8%
|
14
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN
|
Item 1. Security and Issuer.
This Amendment No. 1 (this “Amendment”)
amends and supplements the Schedule 13D (the “Schedule 13D”) filed September 20, 2019, by and on behalf
of P2 Capital Master Fund I, L.P., a Cayman Islands exempted limited partnership (“Master Fund I”), P2 Capital
Master Fund VI, L.P., a Delaware limited partnership (“Master Fund VI”), P2 Capital Master Fund XII, L.P.,
a Delaware limited partnership (“Master Fund XII” and, together with Master Fund I and Master Fund VI, the “Funds”),
P2 Capital Partners, LLC, a Delaware limited liability company (the “Manager”) and Claus Moller, a citizen of
Denmark (all the preceding persons are the “Reporting Persons”), relating to the shares of Common Stock, $.01
par value (the “Shares”) of Acadia Healthcare Company, Inc., a Delaware corporation (the “Issuer”).
Information reported in the Schedule 13D remains in effect except to the extent that it is amended, restated or superseded by information
contained in this Amendment. Capitalized terms used herein but not otherwise defined in this Amendment shall have the meanings
ascribed to them in the Schedule 13D.
Item 3. Source and Amount of Funds or Other Consideration.
Item 3 is hereby amended and replaced by
the following:
The source of funds
for the purchases of the Shares reported on herein was cash on hand and the general working capital of the respective purchasers,
which may, at any given time, include margin loans made by brokerage firms in the ordinary course of business.
As of December 11,
2020, Master Fund I had invested $66,430,134 (excluding brokerage commissions) in the Shares of the Issuer, Master Fund VI had
invested $62,850,415 (excluding brokerage commissions) in the Shares of the Issuer, and Master Fund XII had invested $0 in the
Shares of the Issuer.
Item 5. Interest in Securities of Issuer.
(a), (b): The responses
of the Reporting Persons to Rows (7) through (13) of the cover pages of this Statement on Schedule 13D are incorporated
herein by reference. On December 10, 2020, Master Fund I delivered 590,000 Shares to its broker in connection with settlement
of open market sales previously executed. On December 10, 2020, Master Fund VI delivered 500,000 Shares to its broker in connection
with settlement of open market sales previously executed. As of the close of business on December 11, 2020, Master Fund I
beneficially owned an aggregate of 2,217,866 Shares, representing approximately 2.5% of the outstanding Shares, Master Fund VI
beneficially owned an aggregate of 2,095,754 Shares, representing approximately 2.4% of the outstanding Shares, and Master Fund
XII beneficially owned 0 Shares, representing 0.0% of the outstanding Shares. As of the close of business on December 11,
2020, each of the Manager and Mr. Moller may be deemed to beneficially own 4,313,620 Shares, in the aggregate, which represented
approximately 4.8% of the outstanding Shares. All percentages set forth in this paragraph are based on 88,991,252 shares of Common
Stock, $.01 par value outstanding (as of October 30, 2020), which number of Shares is based upon the number of shares of Common
Stock, $.01 par value reported as outstanding at October 30, 2020 in the Issuer’s Report on Form 10-Q filed on
October 30, 2020 for the quarter ended September 30, 2020.
Each of the Reporting
Persons owns less than 5.0% of the outstanding Shares and therefore the Reporting Persons are no longer required to file amendments
to this Schedule 13D.
Each of the Funds is
the direct owner of the Shares reported owned by it. For purposes of disclosing the number of Shares beneficially owned by each
of the Reporting Persons, the Manager, as investment manager of the Funds, and Mr. Moller, as managing member of the Manager,
may be deemed to own beneficially (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) all Shares
that are owned beneficially and directly by the Funds. Each of the Manager and Mr. Moller disclaims beneficial ownership of
such Shares for all other purposes. Master Fund I and Master Fund VI each disclaim beneficial ownership of the Shares held
directly by the other.
(c) Except as
set forth above or in Schedule I, no Reporting Person has effected any transaction in the Shares during the 60 days preceding the
date hereof.
(d) Not applicable.
(e) Not applicable.
SIGNATURE
After reasonable inquiry and
to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: December 11, 2020
P2 CAPITAL MASTER FUND I, L.P.
|
|
P2 CAPITAL MASTER FUND VI, L.P.
|
|
|
|
By:
|
P2 Capital Partners, LLC,
|
|
By:
|
P2 Capital Partners, LLC,
|
|
as Investment Manager
|
|
|
as Investment Manager
|
|
|
|
|
|
|
By:
|
s/Claus Moller
|
|
|
By:
|
s/Claus Moller
|
|
|
Name: Claus Moller
|
|
|
|
Name: Claus Moller
|
|
|
Title: Managing Member
|
|
|
|
Title: Managing Member
|
|
|
|
|
|
P2 CAPITAL MASTER FUND XII, L.P.
|
|
P2 CAPITAL PARTNERS, LLC
|
|
|
|
By:
|
P2 Capital Partners, LLC,
|
|
|
|
|
as Investment Manager
|
|
|
By:
|
s/Claus Moller
|
|
|
|
|
|
Name: Claus Moller
|
|
By:
|
s/Claus Moller
|
|
|
|
Title: Managing Member
|
|
|
Name: Claus Moller
|
|
|
|
|
|
Title: Managing Member
|
|
|
|
|
|
|
|
|
CLAUS MOLLER
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
s/Claus Moller
|
|
|
|
Schedule I
TRANSACTIONS IN THE PAST SIXTY DAYS BY THE REPORTING PERSONS
The following table sets forth all transactions
with respect to the Common Stock, $.01 par value of the Issuer effected during the past sixty (60) days by any of the Reporting
Persons. The purchase and sale transactions occurred on the open market and the reported price per share excludes brokerage commissions.
Shares Purchased/(Sold) by Manager
on behalf of Master Fund I
Number of Shares Purchased/(Sold)
|
Price Per Share
|
Date
|
(10,547)
|
32.6998
|
10/21/20
|
(227,141)
|
31.4501
|
10/22/20
|
(5,000)
|
42.4014
|
11/30/20
|
(5,000)
|
42.5036
|
12/1/20
|
(5,000)
|
42.1088
|
12/2/20
|
(6,819)
|
41.9287
|
12/3/20
|
(3,000)
|
42.4333
|
12/4/20
|
(56,856)
|
47.5696
|
12/10/20
|
Shares Purchased/(Sold) by Manager
on behalf of Master Fund VI
Number of Shares Purchased/(Sold)
|
Price Per Share
|
Date
|
(5,274)
|
32.6998
|
10/21/20
|
(232,859)
|
31.4501
|
10/22/20
|
(4,500)
|
42.4333
|
12/4/20
|
(85,284)
|
47.5696
|
12/10/20
|
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Sep 2023 to Sep 2024